Yu et al indicated that MetaLnc9 could interact with the glycolytic kinase PGK1 and prevent its ubiquitination in NSCLC cells, resulting in activation of the oncogenic AKT/mTOR signalling pathway.95 The gene discussed is AKT1; the disease is non-small cell lung carcinoma.